These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29162644)

  • 1. A role for astroglia in prion diseases.
    Aguzzi A; Liu Y
    J Exp Med; 2017 Dec; 214(12):3477-3479. PubMed ID: 29162644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human stem cell-derived astrocytes replicate human prions in a
    Krejciova Z; Alibhai J; Zhao C; Krencik R; Rzechorzek NM; Ullian EM; Manson J; Ironside JW; Head MW; Chandran S
    J Exp Med; 2017 Dec; 214(12):3481-3495. PubMed ID: 29141869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of PRNP polymorphisms on human prion disease susceptibility: an update.
    Kobayashi A; Teruya K; Matsuura Y; Shirai T; Nakamura Y; Yamada M; Mizusawa H; Mohri S; Kitamoto T
    Acta Neuropathol; 2015 Aug; 130(2):159-70. PubMed ID: 26022925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.
    Asante EA; Gowland I; Grimshaw A; Linehan JM; Smidak M; Houghton R; Osiguwa O; Tomlinson A; Joiner S; Brandner S; Wadsworth JDF; Collinge J
    J Gen Virol; 2009 Mar; 90(Pt 3):546-558. PubMed ID: 19218199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic Creutzfeldt-Jakob disease infected human cerebral organoids retain the original human brain subtype features following transmission to humanized transgenic mice.
    Groveman BR; Race B; Foliaki ST; Williams K; Hughson AG; Baune C; Zanusso G; Haigh CL
    Acta Neuropathol Commun; 2023 Feb; 11(1):28. PubMed ID: 36788566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programme.
    Mead S; Khalili-Shirazi A; Potter C; Mok T; Nihat A; Hyare H; Canning S; Schmidt C; Campbell T; Darwent L; Muirhead N; Ebsworth N; Hextall P; Wakeling M; Linehan J; Libri V; Williams B; Jaunmuktane Z; Brandner S; Rudge P; Collinge J
    Lancet Neurol; 2022 Apr; 21(4):342-354. PubMed ID: 35305340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prion diseases.
    Brown K; Mastrianni JA
    J Geriatr Psychiatry Neurol; 2010 Dec; 23(4):277-98. PubMed ID: 20938044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive neuropathologic analysis of genetic prion disease associated with the E196K mutation in PRNP reveals phenotypic heterogeneity.
    Eigenbrod S; Frick P; Giese A; Schelzke G; Zerr I; Kretzschmar HA
    J Neuropathol Exp Neurol; 2011 Mar; 70(3):192-200. PubMed ID: 21293298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prion diseases, update].
    Kitamoto T
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1223-5. PubMed ID: 12235843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic studies in human prion diseases.
    Jeong BH; Kim YS
    J Korean Med Sci; 2014 May; 29(5):623-32. PubMed ID: 24851016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
    Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
    Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report about four novel mutations in the prion protein gene.
    Schelzke G; Stoeck K; Eigenbrod S; Grasbon-Frodl E; Raddatz LM; Ponto C; Kretzschmar HA; Zerr I
    Dement Geriatr Cogn Disord; 2013; 35(3-4):229-37. PubMed ID: 23467330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein transgenes and the neuropathology in prion diseases.
    DeArmond SJ; Prusiner SB
    Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An astrocyte cell line that differentially propagates murine prions.
    Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
    J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology and genetics of prion diseases.
    Prusiner SB
    Annu Rev Microbiol; 1994; 48():655-86. PubMed ID: 7826022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinacrine promotes replication and conformational mutation of chronic wasting disease prions.
    Bian J; Kang HE; Telling GC
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):6028-33. PubMed ID: 24711410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of prion diseases in France. French Research Group on Epidemiology of Human Spongiform Encephalopathies.
    Laplanche JL; Delasnerie-Lauprêtre N; Brandel JP; Chatelain J; Beaudry P; Alpérovitch A; Launay JM
    Neurology; 1994 Dec; 44(12):2347-51. PubMed ID: 7991124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion diseases.
    McKintosh E; Tabrizi SJ; Collinge J
    J Neurovirol; 2003 Apr; 9(2):183-93. PubMed ID: 12707849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular approaches to mechanisms of prion diseases.
    Bratosiewicz-Wasik J; Wasik TJ; Liberski PP
    Folia Neuropathol; 2004; 42 Suppl A():33-46. PubMed ID: 15449458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a class of diketopiperazines as antiprion compounds.
    Bolognesi ML; Ai Tran HN; Staderini M; Monaco A; López-Cobeñas A; Bongarzone S; Biarnés X; López-Alvarado P; Cabezas N; Caramelli M; Carloni P; Menéndez JC; Legname G
    ChemMedChem; 2010 Aug; 5(8):1324-34. PubMed ID: 20540064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.